Abstract
Recent advances in combinatorial chemistry (CC) and High throughput screening (HTS) approaches for use in drug discovery have made it possible to synthesize and/or screen large repositories of chemically diverse scaffolds in search of small molecules that disrupt or regulate macromolecular function. Although successful in the discovery of novel therapeutics this approach is both costly and time consuming. In silico computer aided drug discovery (CADD) approaches including; structure based virtual screening (SBVS) or high throughput docking (HTD) and/or ligand based virtual screening (LBVS) are areas experiencing renewed interest both in the pharmaceutical industry and academia. The emerging success of these approaches alone or partnered with HTS platforms in search of, and/or optimization of, novel therapeutic compounds represents a potential approach for the identification of therapies that target novel space. Here we will discuss how LBVS has been and continues to be partnered with HTS in early stage compound identification and/or triage. We will also provide a significant overview of how SBVS when partnered with LBVS can overcome the limitations inherent to each approach when used alone. We will discuss this partnered approach in the context of both traditional drug discovery targets and provide thoughts on its applicability to study novel chemical space including protein-protein and/or other historical intractable interfaces.
Keywords: Chemical genetics, high throughput screening (HTS), ligand based virtual screening (LBVS), structure based virtual screening (SBVS)
Combinatorial Chemistry & High Throughput Screening
Title: Exploring Novel Target Space: A Need to Partner High Throughput Docking and Ligand-Based Similarity Searches?
Volume: 12 Issue: 10
Author(s): Kumaran Shanmugasundaram and Alan C. Rigby
Affiliation:
Keywords: Chemical genetics, high throughput screening (HTS), ligand based virtual screening (LBVS), structure based virtual screening (SBVS)
Abstract: Recent advances in combinatorial chemistry (CC) and High throughput screening (HTS) approaches for use in drug discovery have made it possible to synthesize and/or screen large repositories of chemically diverse scaffolds in search of small molecules that disrupt or regulate macromolecular function. Although successful in the discovery of novel therapeutics this approach is both costly and time consuming. In silico computer aided drug discovery (CADD) approaches including; structure based virtual screening (SBVS) or high throughput docking (HTD) and/or ligand based virtual screening (LBVS) are areas experiencing renewed interest both in the pharmaceutical industry and academia. The emerging success of these approaches alone or partnered with HTS platforms in search of, and/or optimization of, novel therapeutic compounds represents a potential approach for the identification of therapies that target novel space. Here we will discuss how LBVS has been and continues to be partnered with HTS in early stage compound identification and/or triage. We will also provide a significant overview of how SBVS when partnered with LBVS can overcome the limitations inherent to each approach when used alone. We will discuss this partnered approach in the context of both traditional drug discovery targets and provide thoughts on its applicability to study novel chemical space including protein-protein and/or other historical intractable interfaces.
Export Options
About this article
Cite this article as:
Shanmugasundaram Kumaran and Rigby C. Alan, Exploring Novel Target Space: A Need to Partner High Throughput Docking and Ligand-Based Similarity Searches?, Combinatorial Chemistry & High Throughput Screening 2009; 12 (10) . https://dx.doi.org/10.2174/138620709789824709
DOI https://dx.doi.org/10.2174/138620709789824709 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |
Call for Papers in Thematic Issues
Artificial Intelligence Methods for Biomedical, Biochemical and Bioinformatics Problems
Recently, a large number of technologies based on artificial intelligence have been developed and applied to solve a diverse range of problems in the areas of biomedical, biochemical and bioinformatics problems. By utilizing powerful computing resources and massive amounts of data, methods based on artificial intelligence can significantly improve the ...read more
Eco-friendly Agents for Biological Control of Pathogenic Diseases
The discovery of an alternative biological approach to disease management includes work on medicinal products derived from natural sources as a starting point for the development of eco-friendly agents for these diseases and the injuries they cause, as well as reducing human contact with hazardous chemicals and their residues. We ...read more
Emerging trends in diseases mechanisms, noble drug targets and therapeutic strategies: focus on immunological and inflammatory disorders
Recently infectious and inflammatory diseases have been a key concern worldwide due to tremendous morbidity and mortality world Wide. Recent, nCOVID-9 pandemic is a good example for the emerging infectious disease outbreak. The world is facing many emerging and re-emerging diseases out breaks at present however, there is huge lack ...read more
Exploring Spectral Graph Theory in Combinatorial Chemistry
Scope of the Thematic Issue: Combinatorial chemistry involves the synthesis and analysis of a large number of diverse compounds simultaneously. Traditional methods rely on brute force experimentation, which can be time-consuming and resource-intensive. Spectral Graph Theory, a branch of mathematics dealing with the properties of graphs in relation to the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Modulating Effects of Endogenous Substances on Drug Metabolising Enzymes and Implications for Inter-Individual Variability and Quantitative Prediction
Current Drug Metabolism Peptidic Tumor Targeting Agents: The Road from Phage Display Peptide Selections to Clinical Applications
Current Pharmaceutical Design YB-1 Protein and Multidrug Resistance of Tumor Cells
Current Signal Transduction Therapy Telomere Length Variations in Aging and Age-Related Diseases
Current Aging Science Single Photon Emission Tomography in the Diagnostic Assessment of Cardiac and Vascular Infectious Diseases
Current Radiopharmaceuticals Inhibitors of the PI3K/Akt/mTOR Pathway: New Hope for Breast Cancer Patients
Recent Patents on Anti-Cancer Drug Discovery Multidisciplinary Cancer Therapy with Telomerase-Specific Oncolytic Adenovirus
Current Cancer Therapy Reviews Recent Development of Low-dose X-ray Cone-beam Computed Tomography
Current Medical Imaging Dual Inhibitors of PI3K/mTOR or mTOR-Selective Inhibitors: Which Way Shall We Go?
Current Medicinal Chemistry Advances in Targeting Insulin-like Growth Factor Signaling Pathway in Cancer Treatment
Current Pharmaceutical Design Application and Future Prospect of Extracellular Matrix Targeted Nanomaterials in Tumor Theranostics
Current Drug Targets Pharmacometrics of Stilbenes: Seguing Towards the Clinic
Current Clinical Pharmacology Peripheral and Central Glutamate Dyshomeostasis in Neurodegenerative Disorders
Current Neuropharmacology The Use of the Inhibitory Receptors for Modulating the Immune Responses
Current Pharmaceutical Design Nanoceria: Synthesis and Biomedical Applications
Current Nanoscience Role of Iodine in Metabolism
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery BRCA1 as Target for Breast Cancer Prevention and Therapy
Anti-Cancer Agents in Medicinal Chemistry Serenoa Repens, Lycopene and Selenium: A Triple Therapeutic Approach to Manage Benign Prostatic Hyperplasia
Current Medicinal Chemistry The Interaction of Isoflavone Phytoestrogens with ER<sub>α</sub> and ER<sub>β</sub> by Molecular Docking and Molecular Dynamics Simulations
Current Computer-Aided Drug Design Novel Marine-Derived Anti-Cancer Agents
Current Pharmaceutical Design